COL6A2 and metastatic malignant neoplasm in the lymph nodes: Moreover, increased COL6A2 expression was positively associated with aggressive clinicopathological features of ccRCC, such as advanced T stage, lymph node metastasis, higher histological grade, and later pathological stage.